Glutathione

What is Glutathione?

Glutathione (known chemically as Reduced Glutathione or GSH) is an endogenous, low-molecular-weight tripeptide composed of glutamate, cysteine, and glycine. Widely recognized as the primary intracellular “master antioxidant,” it is present in high concentrations across almost all cellular tissues. Researchers investigate this compound for its fundamental role in neutralizing reactive oxygen species (ROS), protecting mitochondrial DNA from oxidative decay, and driving Phase II hepatic detoxification pathways.

For laboratory and in vitro evaluation, researchers often choose to buy Glutathione in high-purity 600MG / 1500MG lyophilized powder formats, or as a pre-solubilized 200MG/ML liquid compound. Because the liquid matrix is highly susceptible to atmospheric oxidation, the 200MG/ML presentation must be stored under continuous refrigeration to preserve its active, reduced state and prevent structural degradation into its inactive disulfide form (GSSG). Lyophilized powders can be securely prepared using specialized reconstitution solution to ensure structural stability right before assay deployment.

Chemical and Molecular Data

What are the Mechanisms of Action?

The biochemical pathways and cellular targets of Glutathione include:

• Direct Electrophilic Scavenging: Research demonstrates that the active sulfhydryl (-SH) group on the cysteine residue serves as a strong electron donor. This enables GSH to directly reduce free radicals and reactive oxygen species (ROS), such as hydroxyl radicals and hydrogen peroxide, converting them into harmless baseline metabolic bioproducts.
• Enzymatic Co-substrate Activation: In addition to direct radical neutralization, Glutathione serves as an obligatory co-substrate for Glutathione Peroxidase (GPx) enzymes. This specific interaction catalyzes the reduction of damaging lipid hydroperoxides, preserving the structural integrity of cellular lipid bilayers.
• Phase II Xenobiotic Conjugation: Studies indicate that GSH acts as a primary substrate for Glutathione S-Transferase (GST) enzymes. Within hepatic tissue assays, GST catalyzes the conjugation of reduced Glutathione onto hydrophobic xenobiotics and electrophilic toxins, rendering them highly water-soluble for cellular excretion.

What are the Clinical & Preclinical Trials on Glutathione?

When evaluating research efficacy and published experimental literature:

• Hepatic Integrity and Toxic Mitigation: Preclinical models evaluating chemically induced hepatotoxicity demonstrated that targeted administration of reduced GSH completely preserves mitochondrial membrane potentials. It directly limits intracellular lipid peroxidation and maintains baseline tissue metabolic capacity under heavy toxic stress.
• Liquid Phase Temperature Degradation Assays: Analytical chemistry reviews focusing on solution stability show that un-refrigerated liquid GSH undergoes rapid ambient autoxidation, highlighting that maintaining exact temperature parameters (2°C to 8°C) for the 200MG/ML matrix is mandatory to halt the production of oxidized GSSG disulfides.
• Cellular Longevity and Redox Rebalancing: In vitro trials utilizing senescent cell cultures document that maintaining adequate intracellular GSH pools prevents standard downstream telomeric erosion and preserves healthy cellular signaling dynamics during extended replication mapping.

How does Glutathione compare to other compounds?

To evaluate absolute cellular accumulation, oral bioavailability profiles, and specific conversion cascades, researchers compare standard Glutathione against chemical precursor variants and acetylated configurations: